MSCI IncNYSE: MSCI
Financials · Financial Exchanges & Data
$581.51
-2.58%
Vol: 539K
Research Digest
Friday, June 19, 2026
MSCI named Kashi Kakarla CTO effective June 22 and released its 2026 Global Market Accessibility Review covering 79 markets, with a Korea reclassification in focus for June 23.
MSCI appointed Kashi Kakarla as Chief Technology Officer and Head of Product Engineering, effective June 22, 2026. The company also released its MSCI 2026 Global Market Accessibility Review, assessing accessibility across 79 markets, with investors focused on the upcoming June 23 review that could affect South Korea's market classification and Bulgaria's status. A South Korea upgrade would be significant because it could reshape index flows and weightings tied to MSCI products. The stock was recently upgraded to a Zacks Rank #2 (Buy) as analysts raised earnings estimates, with a consensus Buy rating and an average price target around $688. The shares traded near $600 (June 17). The risk is that any classification decision disappoints expectations and that index-flow impacts are gradual rather than immediate.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17MSCI is in focus ahead of its June 18/23 market-classification reviews, with a potential Indonesia downgrade that could trigger up to $13 billion in fund outflows.Mixed▶
On June 15, 2026 Bloomberg reported that MSCI is weighing whether to downgrade Indonesia from emerging- to frontier-market status, a decision that analysts say could prompt global funds to withdraw as much as $13 billion. MSCI will release results of its 2026 Global Market Accessibility Review on June 18 and its Annual Market Classification Review on June 23, with a possible South Korea upgrade to developed-market status that could draw ~$30 billion in inflows also in play. The company also published a new investor presentation on June 15 and named Kashi Kakarla CTO on June 3. The bull case is strong Q1 FY2026 results and momentum in index, analytics and private-markets data, with UBS lifting its target to $720; the bear case is that classification decisions are binary events that can stoke regional volatility and headline risk around MSCI's benchmark franchise.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours. The CTO appointment of Kashi Kakarla was announced June 3, which is outside the 48-hour window.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21MSCI announces May 2026 Index Review; 49 adds and 101 deletes to ACWINeutral▶
MSCI announced May 2026 Index Review results on May 12, 2026, implementing changes at close of May 29. Forty-nine securities added and 101 deleted from MSCI ACWI Index. Largest World Index additions: Medline A, MasTec, TechnipFMC. Largest EM additions: Itau Unibanco, Yangtze Optical Fibre, Sichuan Biokin. Small Cap: 246 adds, 195 deletes. Greece to be reclassified from EM to Developed Market in May 2027. Dividend of $2.05/share payable May 29. Acquired PM Insights for private markets data.
May 20MSCI completed its May 2026 Index Review (49 ACWI additions, 101 deletions; changes implemented May 29) and disclosed the acquisition of private-markets data firm PM Insights covering ~$5.5T in private equity value.Neutral▶
MSCI announced results of its May 2026 Equity Index Review on May 12, with 49 securities added and 101 deleted from the MSCI ACWI Index, including new additions Medline, MasTec and TechnipFMC to the World Index; changes take effect at the close of May 29. The Emerging Markets Index adds Itau Unibanco, Yangtze Optical Fibre and Sichuan Biokin Pharmaceutical, while 246 names enter and 195 exit the ACWI Small Cap Index. MSCI also announced it will reclassify the MSCI Greece Indexes from Emerging to Developed Market status at the May 2027 review. Separately, MSCI disclosed the acquisition of PM Insights, a private markets data and analytics specialist covering an estimated $5.5T in private company equity market value. Shares eased ~1.75% in the short term but show a 9.32% 90-day return. Risks: ongoing fee-pressure narrative in index/data and integration risk for the PM Insights deal.
May 19MSCI announced May 2026 Index Review with 49 ACWI additions and 101 deletions; Greece set for DM reclassification in May 2027.Neutral▶
On May 12, 2026, MSCI announced the May 2026 Index Review results effective close of May 29. MSCI ACWI Index adds 49 securities and deletes 101; largest World additions: Medline A, MasTec, TechnipFMC. Largest EM additions: Itau Unibanco, Yangtze Optical Fibre, Sichuan Biokin. ACWI Small Cap adds 246 / deletes 195. MSCI Greece Indexes to be reclassified from EM to DM in single step at May 2027 Index Review. Frontier Markets adds five securities. Bear case: 1-day return -1.75% and 7-day -1.93%; high-multiple data stock vulnerable to rate moves.
May 18No significant overnight updatesNeutral▶
No material news in the last 48 hours. The most recent material event was the May 12, 2026 May Index Review announcement.
May 15MSCI trades around $570 with Strong Buy consensus and $682 average PT after Q1 2026 revenue grew 14.1% to $850.8M, with upcoming $2.05/share dividend.Positive▶
MSCI Inc. delivered Q1 2026 revenue of $850.8M, up 14.1% YoY, driven by record subscription growth and AI integration; EPS rose 11.7% YoY. The company is going ex-dividend soon with a $2.05/share quarterly payout, continuing a 10-year average annual dividend increase of 25%. MSCI also acquired PM Insights to expand its objective pricing and valuation data offerings. Analyst consensus is Strong Buy with a 12-month PT of $682.44 (~14% upside from $570.91 close on 5/13). Risk: rich 33x P/E leaves limited cushion if subscription growth decelerates or active fund outflows accelerate.
May 14MSCI announces May 2026 Index Review with 49 ACWI adds and 101 deletes implementing May 29, plus PM Insights acquisition and Greece DM reclassification pathNeutral▶
On May 12, 2026 MSCI announced the results of its May 2026 Equity Index Review, with all changes implemented at the close of May 29. Forty-nine securities were added to and 101 deleted from the MSCI ACWI Index; the three largest World Index additions were Medline A, MasTec and TechnipFMC. MSCI Greece will be reclassified from Emerging to Developed Market status in one step coinciding with the May 2027 review. CGS International estimates roughly $1.8B in passive outflows tied to the Indonesia rebalancing. MSCI also acquired PM Insights, a private markets data and analytics firm. Q1 2026 results showed $850.8M in revenue with a $2.05 dividend declared. Risk: passive-flow reversals and ongoing fee compression in index licensing.
May 13MSCI announced May 2026 Index Review results on May 12, removing Indonesian billionaire-linked stocks and adding 49 securities to the ACWI Index, implementing changes May 29.Neutral▶
On May 12, 2026, MSCI announced the results of its May 2026 Index Review, with 49 securities added and 101 deleted from the MSCI ACWI Index, all changes effective at close of May 29. The largest additions to the MSCI World Index include Medline A, MasTec, and TechnipFMC. MSCI cut Indonesian stocks linked to the country's richest billionaires, including PT Barito Renewables Energy and PT Dian Swastatika Sentosa, after the Indonesia Stock Exchange named them as tightly held. CGS International estimates roughly $1.8 billion of passive outflows tied to the rebalancing. MSCI Greece Indexes will be reclassified from Emerging to Developed Market in May 2027. Shares closed at $583.65 on May 12.
May 12MSCI to announce May 2026 Index Review results today after Q1 beat with 14% revenue growth and analyst upgradePositive▶
MSCI is scheduled to announce the results of its May 2026 Index Review on May 12 after 11pm CEST; changes take effect at close of May 29, affecting global standard, small cap, frontier markets, and value/growth indexes. Q1 2026 results showed 14.1% revenue growth, 13% organic, ~14% adjusted EPS growth, ~19% adjusted EBITDA growth, with EPS of $4.55 (vs $4.38-$4.40 consensus) and revenue of $850.8M (vs $830.9M est.). Asset-based fees annualized growth rate hit 25% to record $872M. Buybacks of $464M at ~$556/share. Cash dividend of $2.05 declared with May 15 ex-date.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| SPGIS+P | $411.04 | -1.67% | +6.0% | 21.5x | 1.08 | $130.2B |
| MCOMOODY | $451.86 | -0.96% | +4.7% | 26.4x | 1.33 | $85.7B |
| CMECME | $246.29 | -2.47% | +2.4% | 18.3x | 0.28 | $85.5B |
| ICEINTERCONTINENTAL | $133.97 | -0.46% | +4.9% | 15.1x | 0.95 | $75.2B |
| NDAQNASDAQ | $82.27 | -1.22% | +2.3% | 19.1x | 1.00 | $47.9B |
| MSCIMSCI | $581.51 | -2.58% | +3.6% | 26.8x | 1.24 | $43.9B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price above both MAs — bullish structure.